Approval of third US vaccine could raise question: Which shots are best?
3 weeks 2 days 7 hours ago
Friday, February 26 2021
Feb 26, 2021
February 26, 2021 9:28 AM
February 26, 2021
in
News
Source: Associated Press
Share:
WASHINGTON (AP) The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson & Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?
If cleared for emergency use, the J&J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.
WASHINGTON — The nation is poised to get a third vaccine against covid-19, but because at first glance the Johnson & Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best? If cleared for emergency use, the J&J
Synopsis
Two doses of the Pfizer and Moderna shots were found to be about 95 per cent effective against symptomatic COVID-19. The numbers from J and J s study are not that high, but they are not an apples-to-apples comparison.
AP
The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson and Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?
If cleared for emergency use, the J and J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.
Comparing Pfizer, Moderna and J&J shots isn t an apples-to-apples comparison
While the Johnson & Johnson numbers aren t as high as the effectiveness as Pfizer and Moderna, it s not an apples-to-apples comparison. Author: LAURAN NEERGAARD and MATTHEW PERRONE (Associated Press) Published: 11:38 AM EST February 26, 2021 Updated: 11:54 AM EST February 26, 2021
WASHINGTON The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson & Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?
If cleared for emergency use, the J&J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.
Lauran Neergaard And Matthew Perrone
This July 2020 photo provided by Johnson & Johnson shows a vial of the COVID-19 vaccine in Belgium. The nation is poised to get a third vaccine against COVID-19, but health officials are concerned that at first glance the Johnson & Johnson shot may not be seen as equal to other options from Pfizer and Moderna. (Johnson & Johnson via AP) February 26, 2021 - 3:30 PM
WASHINGTON - U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic.
The acting head of the Food and Drug Administration said in a statement that the agency will move quickly to follow the recommendation, which would make J&Jâs shot the third vaccine authorized for emergency use in the U.S. Vaccinations are picking up speed, but new supplies are urgently needed to stay ahead of a mutating virus that has killed more than 500,000